Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Inflammation × epigallocatechin gallate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1 Liver Neoplasms 1 Liver Cirrhosis 1 Leiomyoma 1 Inflammation 1 Frailty 1 Esophageal Neoplasms 1 Deglutition Disorders 1 Carcinoma, Hepatocellular 1

Interventions

XENP 1595 2 Etanercept 2 salicylsalicylic acid 1 microcrystalline cellulose 1 ginger extract 1 epigallocatechin gallate 1 dapagliflozin 1 cytisine 1 Tablets 1 Sulindac 1 Spirometry 1 Specimen Handling 1 Sodium Salicylate 1 Radiotherapy, Conformal 1 Pregabalin 1 Omeprazole 1 Losartan 1 Ketorolac 1 Interleukin 1 Receptor Antagonist Protein 1 Infliximab 1 Hematologic Tests 1 Diet Therapy 1 Atorvastatin 1 Aspirin 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06068543 2026-03-06

ReFOCUS2

University of Rochester

Phase 2 Recruiting

Frailty, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡